Companies /Healthcare
Unitedhealth Group Inc
NYSE: UNH Healthcare Plans
$406.97
▼ $3.94 (−0.96%) today
Markets closed · 4:40am ET

UnitedHealth Group (UNH) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
57%
EPS beat rate
+2.83%
Avg. EPS surprise
Consecutive EPS beats
UNH vs Market · 30-day return after each reportUNHS&P 500
−20%0%−29.2%+12.6%Q1 25+15.8%+2.2%Q2 25−10.4%−0.5%Q3 25+3.7%−1.4%Q4 25+10.5%+5.5%Q1 26−6.6%+2.9%Q2 26
−20%0%Q1 25Q3 25Q1 26
UNH EPS Trend · estimate vs actualEstimateActual
$0$3$6$7.29$7.20Q1 25$4.45$4.08Q2 25$2.81$2.92Q3 25$2.11$2.11Q4 25$6.60$7.23Q1 26$4.15$4.69Q3 26
$0$3$6Q1 25Q3 25Q1 26
UNH Revenue Trend · estimate vs actualEstimateActual
$0$40.0B$80.0B$120.0B$111.6B$109.6BQ1 25$111.6B$111.6BQ2 25$113.1B$113.2BQ3 25$113.6B$113.2BQ4 25$109.7B$111.7BQ1 26$111.5B$112.7BQ3 26
$0$40.0B$80.0B$120.0BQ1 25Q3 25Q1 26

How Often Does UnitedHealth Group Beat Earnings Estimates?

UnitedHealth Group beat EPS estimates in 4 of its last 7 reported quarters, and has beaten 4 quarters in a row.

UNH quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 Adjusted EPS of $4.69 excludes $0.41/share intangible amortization, $(0.16)/share net gain from portfolio divestitures and South American impacts (including $76 million of incremental losses related to South American businesses held for sale), $(0.08)/share restructuring and other items (including $95 million net decrease in loss contract reserves and $(21) million net valuation losses on equity securities), and $(0.04)/share tax effect of adjustments. $4.69 est. $4.15 +13.03% $112.7B est. $111.5B +1.08%
Q2 2026 $6.38 — $112.0B —
Q1 2026 $7.23 est. $6.60 +9.55% $111.7B est. $109.7B +1.88%
Q4 2025 $2.11 est. $2.11 +0.00% $113.2B est. $113.6B −0.37%
Q3 2025 $2.92 est. $2.81 +3.91% $113.2B est. $113.1B +0.09%
Q2 2025 $4.08 est. $4.45 −8.31% $111.6B est. $111.6B +0.03%
Q1 2025 $7.20 est. $7.29 −1.23% $109.6B est. $111.6B −1.82%

Figures from SEC filings and company reports. Not investment advice.